Výsledky vyhledávání - "Yvonne Wirth"

Efficacy of memantine in delaying clinical worsening in Alzheimer's disease (AD): responder analyses of nine clinical trials with patients with moderate to severe AD

Autor: Yvonne Wirth, Susanne Hartmann, Wolfgang Janetzky, Rainer Hellweg

Publikováno v: International Journal of Geriatric Psychiatry. 27:651-656

Objective Responder analyses are of relevance to evaluate the benefits of a medical treatment. The aim of the current paper is to analyse the response of patients with moderate to severe Alzheimer's disease (AD) to memantine, and clinical relevant re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f32c3ac02a0e8e557c3f84d49181a76b
https://doi.org/10.1002/gps.2766

Zobrazit plný text záznamu

Important Error in ‘Systematic Review and Meta-Analysis of Combination Therapy with Cholinesterase Inhibitors and Memantine in Alzheimer's Disease and Other Dementias' by Muayqil and Camicioli

Autor: Jasmine Fokkens, Michael Tocco, Stephen M. Graham, Yvonne Wirth, Pierre N. Tariot

Publikováno v: Dementia and Geriatric Cognitive Disorders Extra, Vol 4, Iss 2, Pp 122-124 (2014)
Dementia and Geriatric Cognitive Disorders EXTRA

After careful review of the article entitled ‘Systematic review and meta-analysis of combination therapy with cholinesterase inhibitors and memantine in Alzheimer’s disease and other dementias’ [1] , we have identified significant inaccuracies

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94be8e9b24ee57b21af44d58b9632ca6
https://doi.org/10.1159/000359965

Zobrazit plný text záznamu

Memantine in Moderate to Severe Alzheimer’s Disease: a Meta-Analysis of Randomised Clinical Trials

Autor: Hans Jörg Möbius, Yvonne Wirth, Bengt Winblad, Roy W. Jones, Albrecht Stöffler

Publikováno v: Dementia and Geriatric Cognitive Disorders. 24:20-27

The efficacy of memantine in Alzheimer’s disease (AD) has been investigated in multiple randomised, placebo-controlled phase III trials. Recently, the indication label for memantine in Europe was extended to cover patients with moderate to severe A

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dda5ea880a6770c0e78923b07be9e84
https://doi.org/10.1159/000102568

Zobrazit plný text záznamu

Effects of memantine on behavioural symptoms in Alzheimer's disease patients: an analysis of the Neuropsychiatric Inventory (NPI) data of two randomised, controlled studies

Autor: Yvonne Wirth, Serge Gauthier, H. J. Möbius

Publikováno v: International Journal of Geriatric Psychiatry. 20:459-464

Introduction Behavioural symptoms are common in moderate to severe Alzheimer's disease (AD). We have analysed the databases of two randomised studies with regard to the effects of memantine treatment on behavioural symptoms, measured using the 12-ite

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::495d9ae7633e54c3460c436cfcaf7b77
https://doi.org/10.1002/gps.1341

Zobrazit plný text záznamu

Memantine in patients with moderate to severe Alzheimer's disease: meta-analyses using realistic definitions of response

Autor: Yvonne Wirth, Claus Goebel, David Wilkinson

Publikováno v: Dementia and geriatric cognitive disorders. 37(1-2)

Background/Aims: We aimed to develop realistic definitions of clinical worsening in advanced Alzheimer's disease (AD) and to use them in a post hoc responder analysis of memantine. Methods: 2,340 patients with moderate to severe AD (Mini-Mental State

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7698e236c109bf8d79df9d7115797437
https://pubmed.ncbi.nlm.nih.gov/24107324

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání